Thomas Rohrer, MD
MOHS-Micrographic Surgery · Chestnut Hill, MANPI 1053384693
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 369 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. Among mohs-micrographic surgery clinicians in MA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 369 payments — averaging $24.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- UCB, Inc.$770
- Sun Pharmaceutical Industries Inc.$747
- Lilly USA, LLC$614
- Amgen$554
- Johnson & Johnson$534
- plus $4K from 23 others
Across 7 payments — averaging $4810.71 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Aclaris Therapeutics, Inc.$34K
What the payments were for
- Food & beverage$9,021100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 64 | $1,825 |
| UCB, Inc. | 31 | $770 |
| Sun Pharmaceutical Industries Inc. | 34 | $747 |
| Lilly USA, LLC | 27 | $614 |
| Amgen | 21 | $554 |
| Johnson & Johnson | 24 | $534 |
| Novartis | 21 | $519 |
| Galderma Laboratories, L.p. | 21 | $489 |
| Incyte Corporation | 20 | $473 |
| LEO Pharma Inc. | 20 | $466 |
| E.r. Squibb & Sons, L.L.C. | 15 | $354 |
| Regeneron Healthcare Solutions, Inc. | 11 | $233 |
| Sanofi | 8 | $200 |
| Genentech USA, Inc. | 10 | $187 |
| Revance Therapeutics, Inc. | 3 | $153 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 6 | $113 |
| Pfizer | 5 | $113 |
| Boehringer Ingelheim | 4 | $110 |
| Organon | 3 | $89 |
| Bristol Myers Squibb | 4 | $87 |
| Arcutis Biotherapeutics, Inc. | 4 | $85 |
| Dermavant Sciences, Inc. | 4 | $76 |
| Endo Pharmaceuticals Inc. | 1 | $68 |
| Mission Pharmacal Company | 2 | $46 |
| Mylan Pharmaceuticals Inc. | 2 | $33 |
| Botanix SB Inc | 1 | $26 |
| Mayne Pharma Commercial LLC | 1 | $23 |
| Aclaris Therapeutics, Inc. | 1 | $22 |
| Osiris Therapeutics Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BOTOX$413
How this compares
$9,021 in reported general payments places this provider in the 90th percentile of 38 mohs-micrographic surgery providers in Massachusetts.
See all mohs-micrographic surgery providers in Massachusetts →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Hyclate | 82 | $1,315 |
| Fluorouracil | 22 | $1,208 |
| Imiquimod | 14 | $1,200 |
| Calcipotriene | 12 | $1,131 |
| Ketoconazole | 20 | $800 |
| Clobetasol Propionate | 18 | $793 |
| Cephalexin | 78 | $397 |
| Triamcinolone Acetonide | 24 | $343 |
| Mupirocin | 25 | $185 |
Paid to pharmacies, not to this prescriber.
Other mohs-micrographic surgery in Chestnut Hill
- Chrysalyne SchmultsJamaica Plain$58K
- Suzanne OlbrichtBurlington$12K
- Sameer GuptaBoston$11K
- Helen RaynhamNatick$7K
- Omar BadriBeverly$7K
- Benjamin SolkyBoston$7K
- Carin LitaniWellesley Hills$5K
- Christine KannlerBeverly$4K
- Niels KrejciNorwood$4K
- Jonathan WeissBoston$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.